Goserelin (Zoladex) in premenopausal advanced breast cancer: duration of response and survival.
about
Phase II Trial of Goserelin and Exemestane Combination Therapy in Premenopausal Women With Locally Advanced or Metastatic Breast Cancer.Combination goserelin and tamoxifen therapy in premenopausal advanced breast cancer: a multicentre study by the ITMO group. Italian Trials in Medical OncologyAssesssment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer.Endocrine therapy for the treatment of postmenopausal women with breast cancer.LHRH analogues in breast cancer: clever, but do we need them?Tolerability of hormone therapies for breast cancer: how informative are documented symptom profiles in medical notes for 'well-tolerated' treatments?
P2860
Goserelin (Zoladex) in premenopausal advanced breast cancer: duration of response and survival.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Goserelin (Zoladex) in premeno ...... tion of response and survival.
@ast
Goserelin (Zoladex) in premeno ...... tion of response and survival.
@en
type
label
Goserelin (Zoladex) in premeno ...... tion of response and survival.
@ast
Goserelin (Zoladex) in premeno ...... tion of response and survival.
@en
prefLabel
Goserelin (Zoladex) in premeno ...... tion of response and survival.
@ast
Goserelin (Zoladex) in premeno ...... tion of response and survival.
@en
P2093
P2860
P356
P1476
Goserelin (Zoladex) in premeno ...... tion of response and survival.
@en
P2093
Nicholson RI
Robertson JF
P2860
P2888
P304
P356
10.1038/BJC.1990.397
P407
P577
1990-11-01T00:00:00Z
P5875
P6179
1049860367